Tokyo Electron sees significant rise in shares as chip-making equipment expenditures recover. Analysts predict strong growth and increased revenue for ...
Class action lawsuit filed against Amylyx Pharmaceuticals for securities violations, alleging overstated drug prospects and failure to disclose key information. ...